H-CYTE, Inc. (OTCMKTS:HCYTD – Get Free Report)’s stock price traded down 49.5% during trading on Thursday . The stock traded as low as $2.02 and last traded at $2.02. 400 shares changed hands during mid-day trading, an increase of 288% from the average session volume of 103 shares. The stock had previously closed at $4.00.
H-CYTE Price Performance
The company’s 50-day moving average price is $2.02 and its two-hundred day moving average price is $2.02.
H-CYTE Company Profile
H-CYTE, Inc, a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease.
Recommended Stories
- Five stocks we like better than H-CYTE
- 3 Warren Buffett Stocks to Buy Now
- Robinhood Director Sells Millions, But HOOD Stock Eyes Gains
- How to Invest in the FAANG Stocks
- Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill
- How to Use the MarketBeat Dividend Calculator
- Super Micro Computer Stock’s Rally Backed by Strong Financials
Receive News & Ratings for H-CYTE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H-CYTE and related companies with MarketBeat.com's FREE daily email newsletter.
